Emergent Biosolutions Inc. · NYSE:EBS
The Vanguard Group reported a 6.76% stake in Emergent Biosolutions Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group reported a 6.76% stake in Emergent Biosolutions Inc., 3,553,999 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).
- Stake
- 6.76%
- Shares
- 3,553,999
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 6.76% | 3,553,999 |
Source
Related
- Emergent Biosolutions Inc.
- The Vanguard Group
- Emergent Biosolutions Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Form 4 · DeGolyer Donald W · Oct 7, 2026
- Form 4 · Williams Paul Anthony · Oct 5, 2026
- Schedule 13G · American Century Investment Management, Inc. · Aug 14, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026